Priority Date: 12.07.12 (US 201261670931P)

PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES

  • Application ID: EP13817114
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 11 - 50 employees
Company dna gulde hengelhaupt ziebig and schneider
operating since 1990
Headquarter in Berlin and 6 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 12.07.2012 - Priority Date (US 201261670931P)
  • 16.01.2014 - Publication A1 (WO2014012051)
  • 20.05.2015 - Publication A1 (EP2872653)

IPC Classification